BioLineRx (BLRX) Files 5.24M ADS, 2.62M Warrant Shelf for Shareholders
Tweet
Share
E-mailGet Alerts BLRX Hot Sheet
Join SI Premium – FREE
BioLineRx (Nasdaq: BLRX) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to 5,244,301 American Depository Shares, or ADSs, and 2,622,157 warrants to purchase ADSs on behalf of selling shareholders.
BioLineRx will not receive proceeds from the sale.
BioLineRx will not receive proceeds from the sale.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Singularity Future Technology closes $5M registered direct offering
- Werewolf Therapeutics to merge with Ambros in $150M private placement
- EShallGo closes $1.75M registered direct offering at $1 per share
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
